Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Safety and Immunogenicity of a Vero Cell Culture-Derived Whole-Virus Influenza A(H5N1) Vaccine in a Pediatric Population
Authors
Keywords
-
Journal
JOURNAL OF INFECTIOUS DISEASES
Volume 209, Issue 1, Pages 12-23
Publisher
Oxford University Press (OUP)
Online
2013-09-17
DOI
10.1093/infdis/jit498
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Vero cell culture-derived pandemic influenza vaccines: preclinical and clinical development
- (2013) P Noel Barrett et al. Expert Review of Vaccines
- Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries
- (2013) Maria D. Van Kerkhove et al. Influenza and Other Respiratory Viruses
- Antibody Correlates and Predictors of Immunity to Naturally Occurring Influenza in Humans and the Importance of Antibody to the Neuraminidase
- (2013) Robert B. Couch et al. JOURNAL OF INFECTIOUS DISEASES
- Neuraminidase-Inhibiting Antibody Is a Correlate of Cross-Protection against Lethal H5N1 Influenza Virus in Ferrets Immunized with Seasonal Influenza Vaccine
- (2013) S. Rockman et al. JOURNAL OF VIROLOGY
- H5N1 Avian Influenza in Children
- (2012) A. F. Oner et al. CLINICAL INFECTIOUS DISEASES
- Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets
- (2012) Masaki Imai et al. NATURE
- Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells
- (2012) G.-M. Li et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses
- (2012) N. Pica et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets
- (2012) S. Herfst et al. SCIENCE
- Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming
- (2012) Maikel V.W. van der Velden et al. VACCINE
- Homologous and heterologous antibody responses to a one-year booster dose of an MF59®: Adjuvanted A/H5N1 pre-pandemic influenza vaccine in pediatric subjects
- (2012) Timo Vesikari et al. Human Vaccines & Immunotherapeutics
- Boosting Heterosubtypic Neutralization Antibodies in Recipients of 2009 Pandemic H1N1 Influenza Vaccine
- (2011) Chao Qiu et al. CLINICAL INFECTIOUS DISEASES
- Influenza viral neuraminidase: the forgotten antigen
- (2011) Bert E Johansson et al. Expert Review of Vaccines
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
- (2011) Jens Wrammert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- A Vero Cell–Derived Whole-Virus H5N1 Vaccine Effectively Induces Neuraminidase-Inhibiting Antibodies
- (2011) Richard Fritz et al. JOURNAL OF INFECTIOUS DISEASES
- Evidence of Homosubtypic But Not Heterosubtypic Immunity in Young Children Following Wild-type Influenza Illness
- (2011) Christopher S. Ambrose et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- H5N1 Whole-Virus Vaccine Induces Neutralizing Antibodies in Humans Which Are Protective in a Mouse Passive Transfer Model
- (2011) M. Keith Howard et al. PLoS One
- Acquisition of Human-Type Receptor Binding Specificity by New H5N1 Influenza Virus Sublineages during Their Emergence in Birds in Egypt
- (2011) Yohei Watanabe et al. PLoS Pathogens
- Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial
- (2010) Karl G Nicholson et al. LANCET INFECTIOUS DISEASES
- Immunogenicity and Safety of MF59-Adjuvanted H5N1 Influenza Vaccine From Infancy to Adolescence
- (2010) T. Vesikari et al. PEDIATRICS
- Safety and immunogenicity of adjuvanted inactivated split-virion and whole-virion influenza A (H5N1) vaccines in children: A phase I–II randomized trial
- (2010) Jiang Wu et al. VACCINE
- Stockpiling prepandemic influenza vaccines: a new cornerstone of pandemic preparedness plans
- (2008) Lance C Jennings et al. LANCET INFECTIOUS DISEASES
- A Clinical Trial of a Whole-Virus H5N1 Vaccine Derived from Cell Culture
- (2008) Hartmut J. Ehrlich et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Humoral and Cell Mediated Immune Responses to Two Formulations of an Inactivated, Split-Virion Influenza A/H5N1 Vaccine in Children
- (2008) Tawee Chotpitayasunondh et al. PLoS One
- Safety and immunogenicity of a prototype adjuvanted inactivated split-virus influenza A (H5N1) vaccine in infants and children
- (2008) Terry Nolan et al. VACCINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now